Establishing the baseline burden of influenza in preparation for the evaluation of a countywide school-based influenza vaccination campaign

Vaccine

Volumn 29, Issue 1, 2010, Pages 123-129

  Grijalva, Carlos G ^a   Zhu, Yuwei ^a   Simonsen, Lone ^b   Griffin, Marie R ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

Epidemiology; Influenza; Live attenuated influenza vaccines; MAARI

Indexed keywords

INFLUENZA VACCINE;

ACUTE RESPIRATORY TRACT DISEASE; ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; EMERGENCY WARD; FEMALE; HEALTH CARE UTILIZATION; HOSPITALIZATION; HUMAN; HYPOTHESIS; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SCHOOL HEALTH SERVICE; SEASON; SEASONAL INFLUENZA; VIRUS LOAD;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMBULATORY CARE; CHILD; CHILD, PRESCHOOL; EMERGENCY MEDICAL SERVICES; FEMALE; HOSPITALIZATION; HUMANS; INCIDENCE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; ORTHOMYXOVIRIDAE; SCHOOLS; STUDENTS; TENNESSEE; VACCINATION; YOUNG ADULT;

EID: 78649718927     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.08.072     Document Type: Article

References (42)

1. Neuzil K.M., Mellen B.G., Wright P.F., Mitchel E.F., Griffin M.R. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N Engl J Med 2000, 342(4):225-231.
2. Izurieta H.S., Thompson W.W., Piotr K., Shay D.K., Davis R.L., DeStefano F., et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med 2000, 342(232):232-239.
3. Glezen W.P. The changing epidemiology of respiratory syncytial virus and influenza: impetus for new control measures. Pediatr Infect Dis J 2004, 23(November (11 Suppl.)):S202-S206.
4. Glezen W.P. Herd protection against influenza. J Clin Virol 2006, 37(December (4)):237-243.
5. Frank A.L., Taber L.H., Wells C.R., Wells J.M., Glezen W.P., Paredes A. Patterns of shedding of myxoviruses and paramyxoviruses in children. J Infect Dis 1981, 144(5):433-441.
6. Glezen W.P. Anatomy of an urban influenza epidemic. Options for the control of influenza II. J Infect Dis 1993, 11-14.
7. Weycker D., Edelsberg J., Halloran M.E., Longini I.M., Nizam A., Ciuryla V., et al. Population-wide benefits of routine vaccination of children against influenza. Vaccine 2005, 23(January (10)):1284-1293.
8. Halloran M.E., Longini I.M. Public health. Community studies for vaccinating schoolchildren against influenza. Science 2006, 311(February (5761)):615-616.
9. Fiore A.E., Shay D.K., Broder K., Iskander J.K., Uyeki T.M., Mootrey G., et al. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep 2009, 58(July (RR-8)):1-52.
10. Schwartz B., Hinman A., Abramson J., Strikas R.A., Allred N., Uyeki T., et al. Universal influenza vaccination in the United States: are we ready? Report of a meeting. J Infect Dis 2006, 194(November (Suppl. 2)):S147-S154.
11. Glezen W.P. Emerging infections: pandemic influenza. Epidemiol Rev 1996, 18:64-76.
12. King J.C., Cummings G.E., Stoddard J., Readmond B.X., Magder L.S., Stong M., et al. A pilot study of the effectiveness of a school-based influenza vaccination program. Pediatrics 2005, 116(December (6)):e868-e873.
13. Daley M.F., Crane L.A., Chandramouli V., Beaty B.L., Barrow J., Allred N., et al. Influenza among healthy young children: changes in parental attitudes and predictors of immunization during the 2003 to 2004 influenza season. Pediatrics 2006, 117(February (2)):e268-e277.
14. Santoli J.M., Szilagyi P.G., Rodewald L.E. Barriers to immunization and missed opportunities. Pediatr Ann 1998, 27(June (6)):366-374.
15. King J.C., Stoddard J.J., Gaglani M.J., Moore K.A., Magder L., McClure E., et al. Effectiveness of school-based influenza vaccination. N Engl J Med 2006, 355(December (24)):2523-2532.
16. Belshe R.B., Gruber W.C., Mendelman P.M., Cho I., Reisinger K., Block S.L., et al. Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine. J Pediatr 2000, 136(2):168-175.
17. Piedra P.A, Gaglani M.J., Kozinetz C.A., Herschler G., Riggs M., Griffith M., et al. Herd immunity in adults against influenza-related illnesses with use of the trivalent-live attenuated influenza vaccine (CAIV-T) in children. Vaccine 2005, 23(February (13)):1540-1548.
18. Belshe R.B., Edwards K.M., Vesikari T., Black S.V., Walker R.E., Hultquist M., et al. Live attenuated versus inactivated influenza vaccine in infants and young children. N Engl J Med 2007, 356(February (7)):685-696.
19. Halloran M.E., Longini I.M., Gaglani M.J., Piedra P.A., Chu H., Herschler G.B., et al. Estimating efficacy of trivalent, cold-adapted, influenza virus vaccine (CAIV-T) against influenza A (H1N1) and B using surveillance cultures. Am J Epidemiol 2003, 158(August (4)):305-311.
20. Rhorer J., Ambrose C.S., Dickinson S., Hamilton H., Oleka N.A., Malinoski F.J., et al. Efficacy of live attenuated influenza vaccine in children: a meta-analysis of nine randomized clinical trials. Vaccine 2009, 27(February (7)):1101-1110.
21. Johnson P.R., Feldman S., Thompson J.M., Mahoney J.D., Wright P.F. Immunity to influenza A virus infection in young children: a comparison of natural infection, live cold-adapted vaccine, and inactivated vaccine. J Infect Dis 1986, 154(1):121-127.
22. Basta N.E., Chao D.L., Halloran M.E., Matrajt L., Longini I.M. Strategies for pandemic and seasonal influenza vaccination of schoolchildren in the United States. Am J Epidemiol 2009, (August).
23. Medlock J., Galvani A.P. Optimizing influenza vaccine distribution. Science 2009, (August).
24. Loeb M., Russell M.L., Moss L., Fonseca K., Fox J., Earn D.J., et al. Effect of influenza vaccination of children on infection rates in Hutterite communities: a randomized trial. JAMA 2010, 303(March(10)):943-950.
25. Poehling K.A., Edwards K.M., Weinberg G.A., Szilagyi P., Staat M.A., Iwane M.K., et al. The underrecognized burden of influenza in young children. N Engl J Med 2006, 355(July (1)):31-40.
26. Grijalva C.G., Zhu Y., Griffin M.R. Evidence of effectiveness from a large county-wide school-based influenza immunization campaign. Vaccine 2009, 27(May (20)):2633-2636.
27. Piedra P.A., Gaglani M.J., Kozinetz C.A., Herschler G.B., Fewlass C., Harvey D., et al. Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children. Pediatrics 2007, 120(September (3)):e553-e564.
28. Piedra P.A., Gaglani M.J., Riggs M., Herschler G., Fewlass C., Watts M., et al. Live attenuated influenza vaccine, trivalent, is safe in healthy children 18 months to 4 years, 5 to 9 years, and 10 to 18 years of age in a community-based, nonrandomized, open-label trial. Pediatrics 2005, 116(September (3)):e397-407.
29. Gaglani M.J., Piedra P.A., Herschler G.B., Griffith M.E., Kozinetz C.A., Riggs M.W., et al. Direct and total effectiveness of the intranasal, live-attenuated, trivalent cold-adapted influenza virus vaccine against the 2000-2001 influenza A(H1N1) and B epidemic in healthy children. Arch Pediatr Adolesc Med 2004, 158(January (1)):65-73.
30. United States Census Bureau: Population Estimates Datasets [internet site]. Available from: [accessed 05.01.2009]. http://www.census.gov/popest/datasets.html.
31. Thompson W.W., Weintraub E., Dhankhar P., Cheng P.Y., Brammer L., Meltzer M.I., et al. Estimates of US influenza-associated deaths made using four different methods. Influenza Other Respi Viruses 2009, 3(January (1)):37-49.
32. Thompson W.W., Comanor L., Shay D.K. Epidemiology of seasonal influenza: use of surveillance data and statistical models to estimate the burden of disease. J Infect Dis 2006, 194(November (Suppl. 2)):S82-S91.
33. Thompson W.W., Shay D.K., Weintraub E., Brammer L., Bridges C.B., Cox N.J., et al. Influenza-associated hospitalizations in the United States. JAMA 2004, 292(11):1333-1340.
34. Schanzer D.L., Tam T.W., Langley J.M., Winchester B.T. Influenza-attributable deaths, Canada 1990-1999. Epidemiol Infect 2007, 135(October (7)):1109-1116.
35. Schanzer D.L., Langley J.M., Tam T.W. Hospitalization attributable to influenza and other viral respiratory illnesses in Canadian children. Pediatr Infect Dis J 2006, 25(September (9)):795-800.
36. Neuzil K.M., Wright P.F., Mitchel E.F., Griffin M.R. The burden of influenza illness in children with asthma and other chronic medical conditions. J Pediatr 2000, 137:856-864.
37. Kirkwood B.R., Sterne J.A.C. Essential Medical Statistics 2003, Blackwell Science, MA. 2nd ed.
38. Olson D.R., Heffernan R.T., Paladini M., Konty K., Weiss D., Mostashari F. Monitoring the impact of influenza by age: emergency department fever and respiratory complaint surveillance in New York City. PLoS Med 2007, 4(August (8)):e247.
39. Perz J.F., Craig A.S., Coffey C.S., Jorgensen D.M., Mitchel E., Hall S., et al. Changes in antibiotic prescribing for children after a community-wide campaign. JAMA 2002, 287(June (23)):3103-3109.
40. Poehling K.A., Talbot H.K., Williams J.V., Zhu Y., Lott J., Patterson L., et al. Impact of a school-based influenza immunization program on disease burden: comparison of two Tennessee counties. Vaccine 2009, 27(May (20)):2695-2700.
41. Jansen A.G., Sanders E.A., Wallinga J., Groen E.J., van Loon A.M., Hoes A.W., et al. Rate-difference method proved satisfactory in estimating the influenza burden in primary care visits. J Clin Epidemiol 2008, 61(August (8)):803-812.
42. Centers for Disease Control and Prevention. National Immunization program. Coverage with individual vaccines and vaccination series [internet site]. Available from: [accessed 15.06.2010]. http://www.cdc.gov/vaccines/stats-surv/imz-coverage.htm.